Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Cash from Operations (2024 - 2025)

Historic Cash from Operations for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$8.7 million.

  • Beta Bionics' Cash from Operations rose 919.59% to -$8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$56.6 million, marking a year-over-year change of. This contributed to the annual value of -$48.3 million for FY2024, which is 4878.41% down from last year.
  • Beta Bionics' Cash from Operations amounted to -$8.7 million in Q3 2025, which was up 919.59% from -$13.6 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Cash from Operations registered a high of -$8.7 million during Q3 2025, and its lowest value of -$20.0 million during Q1 2025.